Ionis Pharmaceuticals (IONS) Selling Pressure 'Unwarranted' - BMO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- Wall Street ends down as US-Iran peace optimism fades
- eToro to acquire TradeZero for up to $231M to expand in US
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Biogen (BIIB) Weakness Overdone on Spinraza Death Fears - Mizuho
September 29, 2017 11:31 AM EDTMizuho Securities analyst Salim Syed defended Biogen (NASDAQ: BIIB) amid worries about Spinraza deaths after the FDA made its FAERS (FDA Adverse Events Reporting System) searchable by drug yesterday.
Today there is a link in circulation showing there have been 9 deaths with Spinraza.... More
Ionis Pharma (IONS) Says Deaths Not Surprising as SMA Patients Die Early - Bloomberg
September 29, 2017 10:14 AM EDTIonis Pharma (NASDAQ: IONS) Says Deaths Not Surprising as SMA Patients Die Early - Bloomberg
... MoreSarepta Therapeutics (SRPT), Ionis Pharma (IONS) Weakness Related Taking Reports Out of Context - Adam F
September 29, 2017 10:07 AM EDTAdam Feurstein weighs in on Ionis Pharma (NASDAQ: IONS) and Sarepta Therapeutics (NASDAQ: SRPT), saying weakness could be from taking death reports out of context.
Todays pastime seems to be searching FDAs FAERS database and tweeting side effects/deaths out of context. $IONS $SRPT
Adam Feuerstein (@adamfeuerstein) September 29, 2017... MoreIonis Pharma (IONS) Pressured, Down 3.5%
September 29, 2017 9:50 AM EDTIonis Pharma (NASDAQ: IONS) Pressured, Down 3.5%
... More